CTRI/2018/07/014819
Active, not recruiting
未知
Assessment of comorbidities among children with cerebral palsy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Armed Forces Medical College
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The children will be included if they fulfill the following criteria:
- •a)Age between 2 to 18 years
- •b)Children previously diagnosed with CP
- •c)Causative insult must be acquired before 2years of age
Exclusion Criteria
- •Exclusion criteria will include:
- •a)Children with known genetic or chromosomal disorder
- •b)Children with clearly identified familial or non\-familial syndromes (without genetic confirmation)
- •c)Children with progressive or neurodegenerative disorders
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
Study on the Clinical markers of children with constipation and the Therapeutic Effect of Xiaoji Tongbian Prescription on internal heat syndrome of constipatioConspitationITMCTR2000004131Affiliated Hospital of Nanjing University of Chinese Medicine
Completed
Not Applicable
Exploratory study of children with Developmental Coordination Disorder (DCD), aged 7-12 years, learning new-motor based skills, post CO-OP intervention (Cognitive Orientation to daily Occupational Performance).Developmental Coordinator Disorder (DCD)Developmental Coordination Disorder (DCD)marked impairment of the performance of motor skillsNL-OMON35113Hogeschool Zuyd6
Not yet recruiting
Not Applicable
CLINICAL PROFILE OF MYCOPLASMA PNEUMONIA INFECTION AMONG CHILDREN WITH PNEUMONIAHealth Condition 1: J157- Pneumonia due to Mycoplasma pneumoniaeCTRI/2020/03/023836Institute of child health and hospital for children
Recruiting
Not Applicable
A Comparative clinical outcome study of Children with Severe Pneumonia at KCMH and ASIAN PICU(PACCMAN)severe pneumonia in childrenTCTR20210929008/A100
Completed
Not Applicable
Prospective clinical study in children with severe haemophilia A to investigate clinical efficacy, immunogenicity, pharmacokinetics, and safety of Human-cl rhFVIIISevere haemophilia AHaematological DisordersHaemophiliaISRCTN71212110Octapharma AG (Switzerland)60